Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Bridgebio Pharma Inc (BBIO)

Bridgebio Pharma Inc (BBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Bridgebio Pharma Inc 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304 USA

www.bridgebio.com Employees: 550 P: 650-391-9740

Description:

BridgeBio Pharma Inc. discovers, develops and innovates drugs for genetic diseases. The Company's product platform consists of Mendelian, Oncology and Gene therapy. Its product pipeline includes BBP-265, BBP-831, BBP-631 and BBP-454 which are in clinical stage. BridgeBio Pharma Inc. is based in CA, United States.

Key Statistics

Overview:

Market Capitalization, $K 5,575,205
Enterprise Value, $K 6,909,825
Shares Outstanding, K 188,990
Annual Sales, $ 9,300 K
Annual Net Income, $ -643,200 K
Last Quarter Sales, $ 2,730 K
Last Quarter Net Income, $ -162,040 K
EBIT, $ -544,370 K
EBITDA, $ -537,880 K
60-Month Beta 1.08
% of Insider Shareholders 24.66%
% of Institutional Shareholders 99.85%
Float, K 142,385
% Float 75.34%
Short Volume Ratio 0.45

Growth:

1-Year Return -10.70%
3-Year Return 107.50%
5-Year Return 113.05%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.86 on 11/12/24
Next Earnings Date 11/14/24
Earnings Per Share ttm -2.89
EPS Growth vs. Prev Qtr 15.69%
EPS Growth vs. Prev Year 20.37%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 3-1 on 12/27/21

BBIO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -74.34%
Profit Margin % -6,916.13%
Debt/Equity -1.41
Price/Sales 584.87
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -6.48
Interest Coverage -7.04
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar